• SearchField_GetLegal

Neurontin

NeurontinNeurontin (the product name for Gabapentin), is a pharmaceutical product manufactured and marketed by Parke-Davis, a subsidiary of Pfizer. The drug was first approved in the United States in 1993, to be used in conjunction with other medications to minimize the risk of seizures in adults. A generic version was approved for sale in 2004.

Neurontin has been prescribed for a broad range of medical conditions, from epilepsy and hot flashes to shingles. It has also been recommended for the treatment of nerve damaging disorders associated with diabetes.

Users have reported a wide array of side effects, from sleepiness and dizziness to aggressive behavior and even increased risk of suicide. Others have experienced blurred vision, fever, tremors and viral infections.

If you’ve suffered any side effect after using Neurontin, we can help. GetLegal has the tools and resources to help you find skilled legal representation to protect your rights. Visit our attorney directory, look for your geographic location and find the best lawyer for your situation.

    Latest Article

      GETLEGAL®ATTORNEY DIRECTORY

      Find Leading Attorneys in Your Area

          NEED PROFESSIONAL HELP?

          Talk to an Attorney

          How It Works

          • Briefly tell us about your case
          • Provide your contact information
          • Choose attorneys to contact you
          • SearchField_GetLegal

          ABOUT GETLEGAL

          Our mission at GetLegal is to develop a family of sites that constitute the most useful, informative, reliable and exciting collection of legal resources on the web. We are constantly working to expand and improve many resources we offer to legal professionals and the public.

          Contact Us : 877-359-7077

          RECENT TWEETS

          NEWSLETTER SIGN-UP

          By submitting information to this site, you give permission to GetLegal, or a partner of GetLegal, to contact you by email.

          Advertise With Us

          © 2008-2021 LawConnect, Inc. All rights reserved. Sitemap | Copyright/DMCA Policy | Privacy Policy | Terms of Use | Disclosures/Disclaimers